RU2019113406A - Method for treating extensive superficial skin lesions - Google Patents

Method for treating extensive superficial skin lesions Download PDF

Info

Publication number
RU2019113406A
RU2019113406A RU2019113406A RU2019113406A RU2019113406A RU 2019113406 A RU2019113406 A RU 2019113406A RU 2019113406 A RU2019113406 A RU 2019113406A RU 2019113406 A RU2019113406 A RU 2019113406A RU 2019113406 A RU2019113406 A RU 2019113406A
Authority
RU
Russia
Prior art keywords
skin lesions
superficial skin
treating extensive
extensive superficial
treating
Prior art date
Application number
RU2019113406A
Other languages
Russian (ru)
Other versions
RU2749369C2 (en
RU2019113406A3 (en
Inventor
Павел Васильевич Смачков
Original Assignee
Общество с ограниченной ответственностью "ПРОФИТ ФАРМ"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество с ограниченной ответственностью "ПРОФИТ ФАРМ" filed Critical Общество с ограниченной ответственностью "ПРОФИТ ФАРМ"
Priority to RU2019113406A priority Critical patent/RU2749369C2/en
Publication of RU2019113406A publication Critical patent/RU2019113406A/en
Publication of RU2019113406A3 publication Critical patent/RU2019113406A3/ru
Application granted granted Critical
Publication of RU2749369C2 publication Critical patent/RU2749369C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/717—Celluloses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Claims (2)

Способ лечения обширных поверхностных повреждений кожи, включающий на фоне медикаментозной терапии местное применение эффективного количества лекарственного средства, в качестве которого используют средство, содержащее ингредиенты, мас. %:A method of treating extensive superficial skin lesions, including, against the background of drug therapy, the local application of an effective amount of a drug, which is used as a tool containing ingredients, wt. %: ГидроксипропилцеллюлозаHydroxypropyl cellulose - 5,0%- 5.0% Лидокаина гидрохлорид (в пересчете на безводное вещество)Lidocaine hydrochloride (calculated as anhydrous substance) - 5,0%- 5.0% 2-аллилоксиэтанол2-allyloxyethanol - 4,0%- 4.0% Нипагин (метилпарагидроксибензоата)Nipagin (methyl parahydroxybenzoate) - 0,15%- 0.15% Нипазол (пропилпарагидроксибензоата)Nipazole (propyl parahydroxybenzoate) - 0,05%- 0.05% Вода очищеннаяPurified water - 85,8%- 85.8%
RU2019113406A 2019-04-30 2019-04-30 Method for treating extensive superficial skin lesions RU2749369C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2019113406A RU2749369C2 (en) 2019-04-30 2019-04-30 Method for treating extensive superficial skin lesions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2019113406A RU2749369C2 (en) 2019-04-30 2019-04-30 Method for treating extensive superficial skin lesions

Publications (3)

Publication Number Publication Date
RU2019113406A true RU2019113406A (en) 2020-10-30
RU2019113406A3 RU2019113406A3 (en) 2021-02-11
RU2749369C2 RU2749369C2 (en) 2021-06-09

Family

ID=73398049

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2019113406A RU2749369C2 (en) 2019-04-30 2019-04-30 Method for treating extensive superficial skin lesions

Country Status (1)

Country Link
RU (1) RU2749369C2 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2719658C (en) * 2008-04-01 2019-10-01 Antipodean Pharmaceuticals, Inc. Compositions and methods for skin care
CN101491492B (en) * 2009-02-04 2011-01-05 北京如日中天科技发展有限公司 Full aloe gelatin
RU2438654C1 (en) * 2010-09-16 2012-01-10 Федеральное Государственное Унитарное Предприятие Научно-Производственный Центр "Фармзащита" Hydrogel composition for treating burns
RU2526183C1 (en) * 2013-02-28 2014-08-20 Федеральное государственное унитарное предприятие Научно-производственный центр "Фармзащита" Федерального медико-биологического агентства (ФГУП НПЦ "Фармзащита" ФМБА России) Haemostatic anti-burn wound-healing composition
EA026104B1 (en) * 2015-04-02 2017-03-31 Общество С Ограниченной Ответственностью "Тектум" Haemostatic and wound healing medicine

Also Published As

Publication number Publication date
RU2749369C2 (en) 2021-06-09
RU2019113406A3 (en) 2021-02-11

Similar Documents

Publication Publication Date Title
CR20230310A (en) Prmt5 inhibitors
WO2021147236A9 (en) Use of substituted aminopropionate compound in treatment of sars-cov-2 infections
PE20191650A1 (en) INDOLINE DERIVATIVES SUBSTITUTED AS INHIBITORS OF DENGUE VIRAL REPLICATION
MX2023009222A (en) Tricyclic-amido-bicyclic prmt5 inhibitors.
MX2023001756A (en) Functionalized peptides as antiviral agents.
LV12634A (en) Watersoluble azole antifungals
AR119158A1 (en) HEREDITARY ANGIOEDEMA TREATMENTS
MX2019010695A (en) Antimicrobial compounds, compositions, and uses thereof.
MX2023000943A (en) Tetrahydropyrazolo-pyrazinyl-dihydroimidazolone or tetrahydropyrazolo-pyridinyl-dihydroimidazolone compounds and methods of using same.
MX2021014161A (en) Methods of treating sjã–gren's syndrome using a bruton's tyrosine kinase inhibitor.
MX2020012336A (en) Pharmaceutical formulation.
MX2022003270A (en) Heterocyclic amide compound, pharmaceutically acceptable salt thereof, and preparation method therefor and use thereof.
ZA202212095B (en) Il4i1 inhibitors and methods of use
PH12019502510A1 (en) Pharmaceutical composition and pharmaceutical dosage form comprising (e)-4-(2-(aminomethyl)-3-fluoroallyloxy)-n-tert-butylbenzamide, process for their preparation, methods for treating and uses thereof
RU2019113406A (en) Method for treating extensive superficial skin lesions
MX2022003845A (en) Medicinal cognitive treatments.
MX2022009898A (en) Dihydronaphthyridinone compound, and preparation method therefor and medical use thereof.
EA202193211A1 (en) TREATMENT OF SYNUCLEOPATHIES
RU2017140348A (en) Drug for the treatment of respiratory diseases in horses and method for its use
ZA202202863B (en) Compounds suitable for the treatment and prophylaxis of muscle wasting and other conditions
MX2023004516A (en) Use of pridopidine and analogs for the treatment of anxiety and depression.
MX2022011240A (en) Immunomodulating urea azalides.
PH12020551620A1 (en) Compositions for preventing or treating dry eye
WO2020047360A8 (en) Benzimidazole compounds and use thereof for treating alzheimer's disease or huntington's disease
RU2009114033A (en) MEANS AND METHOD FOR TREATING ENDOMETRITIS IN COWS